2 Canadian Cannabis Stocks Set to Soar in June 2023

Here are two cannabis stocks that may be worth a speculative bet in June for aggressive growth investors looking to play momentum.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

As an increasing number of countries have legalized or have plans to legalize cannabis at the federal level. Thus, cannabis producers are among the high-growth areas of the market that surged on initial excitement around Canadian legalization in 2017/2018. Since then, a number of manias have popped up, which have resulted in significant valuation surges for these stocks over short periods of time.

However, growth hasn’t materialized as many experts expected in recent years. Many companies in this sector also loaded up on debt and equity financing when times were good. Now, when investors want to see a return on their investment, there really isn’t much to go around.

With that said, there are a couple companies that I think could fit into the speculative bucket for investors betting on a momentum-driven surge in June. While risky, these are two cannabis stocks growth investors may want to keep on the radar, if growth begins to pick up in the coming months.

Canopy Growth

Canopy Growth (TSX:WEED) is a Canadian company that produces and markets cannabis and hemp-based products for both recreational and medical use. Apart from its home country, this organization operates in the United States of America and Germany via various subsidiaries. 

Despite its declining share price and very bearish sentiment in this space, Canopy has been working on upgrading its product pipeline. Recent reports highlight a deal between Canopy and India Ltd. to manufacture Wana-branded edibles in the Canadian market. The contract states that Indiva will get the exclusive rights to produce and supply the products in Canada for five years. This term can be renewed for an extra five years with a mutual agreement. 

Moreover, according to the deal, Canopy Growth will purchase approximately 37.2 million shares of Indiva Ltd. at US$0.0579/share. This amounts to around US$2.2 million, providing the former with a 19.99% stake.  

According to Canopy’s chief executive officer David Klein, this deal will provide the organization with increased control over Wana brand’s value chain. It will also ensure top-grade product manufacturing. For those bullish on the profitability potential of value-added products in this space, this is a small deal that could have a big impact on Canopy’s valuation if investors jump aboard.

Aurora Cannabis

Aurora Cannabis (TSX:ACB) manufactures, distributes and sells cannabis and its related products for consumer and medical use. Its key markets lie in Canada, the E.U., South America, Australia, and the Caribbean.  

This company has recently introduced two high-THC products to their German portfolio. They are meant for medical use but will enable doctors to provide tailored treatment to those patients who have high THC needs. For those who are bullish on growth in the medical marijuana space, this is certainly one treatment to keep an eye on.

Additionally, Aurora has joined forces with Strainprint to assist patients using medical cannabis on their wellness journey. The latter is an app which helps individuals keep track of which CBD and THC levels, ingestion patterns, dosages, strains, etc. are working the best for them. 

Through this partnership, Aurora can support patients on every step on their road to recovery. Furthermore, this application is free to download and is available on both iOS and Android. 

Bottom line

Both companies have strong growth and expansion plans in motion but are clearly speculative bets in this current environment. While I would personally not put any capital to work in these two names right now, I can also see why some investors may be keen on jumping into these stocks on any sort of material catalysts in June.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Great Cannabis Stocks for New Investors

Quality cannabis companies such as Green Thumb can help long-term investors deliver outsized gains in the upcoming decade.

Read more »

A cannabis plant grows.
Cannabis Stocks

Will Canopy Growth Stock Pass $1 in November 2023?

Canopy Growth (TSX:WEED) stock needs to make some major changes if it hopes to get buyers back on board, and…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Canopy Growth Stock a Buy, Sell, or Hold Right Now?

Shares of Canopy Growth are trading 99% below all-time highs. Here's why WEED stock remains a high risk bet, despite…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

What’s Happening With Cannabis Stocks in November 2023?

Cannabis stocks have come a long way in the last five years -- they've dropped a long way. What can…

Read more »

Caution, careful
Cannabis Stocks

Buyer Beware: Canopy Growth Stock Is at Risk of a Bigger Drop

Canopy Growth Corp (TSX:WEED) stock has given investors a rough ride. Here's why it could get worse.

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Cannabis Stocks I’d Buy Over Canopy Growth

Two cannabis stocks were second-fiddles to Canopy Growth before but are better buys today.

Read more »